FURUTA MILANO (Chief Financial Officer) received a stock award from TAKEDA PHARMACEUTICAL CO LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/28/2026ACC: 0001395064-26-000138
DirectorOfficer· Chief Financial Officer
Since Mar 2026
+15.61K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
15.61K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+7.80K
Price / share
—
Trade value
—
% of position
15.6%
4/27/2026
50.10K→57.90K
Total
Net shares
+7.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/27/2026 | A · Award | +7.80K | — | — | 15.6% | 50.10K | 57.90K |
| Total | +7.80K | $0.00 | ||||||
Derivative Transactions1
Tax Obligation Award
Direct
Converts to
Ordinary Shares
7.81K shares
Shares
+7.81K
Strike price
Held after
16.62K
Exercisable
—
4/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Tax Obligation Award Direct | Ordinary Shares7.81K shares | 4/27/2026 | A · Award | +7.81K | — | 16.62K |